European Archives - Page 1453 of 1542 - European Medical Journal

Current and Future Developments in the Treatment of CD30+ Lymphomas

CD30 is a cell membrane protein expressed on the surface of a range of lymphomas, which has important diagnostic, pathogenic, and prognostic roles.

EMJ Oncology 3.2 2015

Hello, and a very warm welcome to the European Medical Journal – Oncology, your trusted source for the latest developments in the field of cancer research…

EMJ

RapidPlan Knowledge-Based Radiotherapy Treatment Planning

Earlier this year, a 76-year-old man with prostate cancer became the first radiotherapy patient in the world whose treatment was planned using…

Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?

This symposium aimed to address the current issues in the management of patients with Type 2 diabetes (T2D) post-acute coronary syndrome (ACS), bringing…

Why Are Incretin-Based Therapies More Efficient in East Asians? Perspectives from the Pathophysiology of Type 2 Diabetes and East Asian Dietary Habits

Type 2 diabetes mellitus (T2D) is one of the most serious global health problems. This is partly a result of its drastic increase in East Asia…

Benefits of Bariatric Surgery and Perioperative Surgical Safety

Obesity is a worldwide problem with numerous associated health problems. The number of patients eligible for surgery outnumber surgical capacity…

Moderate Hypoxia Exposure: A Novel Strategy to Improve Glucose Metabolism in Humans?

The obesity epidemic calls for novel strategies to prevent and treat obesity and its comorbidities. Several studies have indicated that…

The Concept of Early Vascular Ageing – An Update in 2015

Arterial ageing is a process that can be quantified, at least to some degree, by measurement of pulse wave velocity along the aorta…

REST/NRSF Target Genes in Neuronal and Beta Cells: Pathophysiological and Therapeutic Perspectives for Diabetes and Neurodegenerative Disorders

Pancreatic beta and neuronal cells share numerous similarities, including a key transcriptional mechanism of the differentiation programme.

Transforming Growth Factor Beta-Based Therapies, a Potential Modulator of the Immune Response in Type 1 Diabetes?

Immunobiological interventions are proving to be an exciting new area for mobilising the immune response towards certain tumours.